Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Arsenic trioxide for refractory aplastic anemia.

Lin Q, Song Y, Fang B.

Ann Hematol. 2013 Mar;92(3):431-2. doi: 10.1007/s00277-012-1605-0. Epub 2012 Oct 14. No abstract available.

PMID:
23064943
2.

Arsenic trioxide improves hematopoiesis in refractory severe aplastic anemia.

Li N, Song Y, Zhou J, Fang B.

J Hematol Oncol. 2012 Oct 9;5:61. doi: 10.1186/1756-8722-5-61.

3.

Improved outcome of adults with aplastic anaemia treated with arsenic trioxide plus ciclosporin.

Song Y, Li N, Liu Y, Fang B.

Br J Haematol. 2013 Jan;160(2):266-9. doi: 10.1111/bjh.12110. Epub 2012 Nov 1. No abstract available.

PMID:
23116478
4.

Temporary effect of arsenic trioxide treatment of refractory extragonadal germ cell cancer.

Kälkner KM, Ullén A, Wersäll P, Cohn-Cedermark G.

Acta Oncol. 2007;46(6):862-3. No abstract available.

PMID:
17653913
5.

Arsenic trioxide in the treatment of relapsed and refractory acute promyelocytic leukemia.

Asou N.

Intern Med. 2005 Aug;44(8):775-6. No abstract available.

6.

Arsenic trioxide: new clinical experience with an old medication in hematologic malignancies.

Douer D, Tallman MS.

J Clin Oncol. 2005 Apr 1;23(10):2396-410. Review.

PMID:
15800332
7.

Complete response to tacrolimus in a child with severe aplastic anemia resistant to cyclosporin A.

Macartney C, Freilich M, Odame I, Charpentier K, Dror Y.

Pediatr Blood Cancer. 2009 Apr;52(4):525-7. doi: 10.1002/pbc.21751.

PMID:
19058202
8.

Etanercept as a salvage treatment for refractory aplastic anemia.

Dufour C, Giacchino R, Ghezzi P, Tonelli R, Ferretti E, Pitto A, Pistoia V, Lanza T, Svahn J.

Pediatr Blood Cancer. 2009 Apr;52(4):522-5. doi: 10.1002/pbc.21886.

PMID:
19061218
9.

[Pharmacological and clinical properties of arsenic trioxide (Trisenox) for relapse or refractory acute promyelocytic leukemia therapy].

Tajima M.

Nihon Yakurigaku Zasshi. 2005 Jun;125(6):389-96. Review. Japanese. No abstract available.

PMID:
16079563
10.

[Medullary insufficiency anemias].

Boivin P.

Soins. 1990 Dec;(543):29-32. French. No abstract available.

PMID:
2091297
11.

Characterization of myelodysplastic syndrome and aplastic anemia by immunostaining of p53 and hemoglobin F and karyotype analysis: differential diagnosis between refractory anemia and aplastic anemia.

Iwasaki T, Murakami M, Sugisaki C, Sobue S, Ohashi H, Asano H, Suzuki M, Nakamura S, Ito M, Murate T.

Pathol Int. 2008 Jun;58(6):353-60. doi: 10.1111/j.1440-1827.2008.02236.x.

PMID:
18477214
12.

[Research advances on effect of arsenic trioxide on tumor].

Feng CQ, Ma WL, Zheng WL.

Ai Zheng. 2002 Dec;21(12):1386-9. Review. Chinese.

PMID:
12520754
13.

Combination brings long-term remission in acute promyelocytic leukemia refractory for both all-trans retinoic acid and arsenic trioxide.

Sasaki M, Sugimoto K, Isobe Y, Oshimi K.

Eur J Haematol. 2008 Aug;81(2):160. doi: 10.1111/j.1600-0609.2008.01079.x. Epub 2008 Mar 19. No abstract available.

PMID:
18363868
14.

Phase 2 study of arsenic trioxide in patients with relapsed or refractory multiple myeloma.

Hussein MA, Saleh M, Ravandi F, Mason J, Rifkin RM, Ellison R.

Br J Haematol. 2004 May;125(4):470-6.

PMID:
15142117
15.

Combination therapy with rhGM-CSF and rhEpo for two patients with refractory anemia and aplastic anemia.

Takahashi M, Aoki A, Mito M, Nikkuni K, Ohtsuka T, Saitoh H, Moriyama Y, Shibata A.

Hematol Pathol. 1993;7(3):153-8.

PMID:
8244908
16.
17.

Arsenic trioxide in patients with refractory multiple myeloma: a prospective, phase II, single-arm study.

Sanaat Z, Rezazadeh M, Gharamaleki JV, Ziae JE, Esfahani A.

Acta Med Iran. 2011;49(8):504-8.

18.

Acute lung injury induced by arsenic trioxide in a patient with refractory myelodysplastic syndrome.

Hassaballa HA, Lateef OB, Silver MR, Balk RA.

J Crit Care. 2005 Mar;20(1):111-3.

PMID:
16015525
19.
20.

A phase II trial of arsenic trioxide for relapsed and refractory acute lymphoblastic leukemia.

Litzow MR, Lee S, Bennett JM, Dewald GW, Gallagher RE, Jain V, Paietta EM, Racevskis J, Rousey SR, Mazza JJ, Tallman MS.

Haematologica. 2006 Aug;91(8):1105-8. Epub 2006 Jul 25.

Supplemental Content

Support Center